1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-3548
  5. Product Images: Rexulti

Product Images Rexulti

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Rexulti NDC 70518-3548 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Rexulti is a medication sold in a pack of 30 tablets. Each tablet contains 2 mg of Brexpiprazole. This medication is manufactured in Tokyo, Japan by Otsuka Pharma Co. Ltd. The medication is RX ONLY and the NDC number for the same is 70518-3548-00. The lot number and expiry date are missing from the available text. The medication should be stored at room temperature between 20-25°C (88-77°F) with excursions allowed from 15-30°C (59-86°F) according to USP. For usage directions, refer to the package insert. The medication has been repackaged by RemedyRepack Inc. located in Indiana, PA 15701. Keep the medication out of reach of children.*

Chemical Structure - rexulti chem structure

Chemical Structure - rexulti chem structure

Figure 1 - rexulti figure 01

Figure 1 - rexulti figure 01

Figure 2 - rexulti figure 02

Figure 2 - rexulti figure 02

This appears to be a table showing changes in Brexpiprazole PK (pharmacokinetics) due to certain measures such as CYP3A4 inhibitors and inducers, CYP2D6 inhibitors, gastric PH increase, etc. The table shows the changes as fold change and 90% confidence intervals. The interacting drugs mentioned are Crmex, Ketoconazole, Cmex, Quinidine, Rifampin, Cmax, Ticlopidine, and Omeprazole. However, without more context it is difficult to provide a specific and practical application of this information.*

Figure 3 - rexulti figure 03

Figure 3 - rexulti figure 03

This appears to be a table displaying the effect of various drugs on certain substrates. The substrates listed are CYP2D6, PgP, CYP286, CYP3A4, and BCRP. The table lists the PK fold change and 90% confidence intervals for various analytes measures on urine, including Dextromethorphan, Fexofenadine, Bupropion, Lovastatin, and Roswastatin. There is also a column displaying the change relative to a reference without the interacting drug.*

Figure 4 - rexulti figure 04

Figure 4 - rexulti figure 04

This text seems to describe a comparison in the efficacy of two treatments for a medical condition. One treatment is ADT with placebo, and the other is ADT with Brexpiprazole 2 mg. However, the text is incomplete and lacks context, so it is hard to provide further details.*

Figure 5 - rexulti figure 05

Figure 5 - rexulti figure 05

Figure 6 - rexulti figure 06

Figure 6 - rexulti figure 06

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.